Sera Prognostics (SERA) Interest Coverage Ratio (2020 - 2026)
Sera Prognostics (SERA) reported Interest Coverage Ratio of 4680.0 for Q1 2026, down 102.38% on a YoY basis from 196772.73 in Q1 2025, and up 47.73% quarter-over-quarter from 8954.0 in Q4 2025.
Sera Prognostics (SERA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Sera Prognostics has reported Interest Coverage Ratio for 7 years, with the latest figure at 4680.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 102.38% year-over-year to 4680.0; the trailing twelve-month figure through Mar 2026 stood at 5230.57 (down 227.02% YoY), and the FY2025 full-year result was 4056.0, down 210.0% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 4680.0, up from 8954.0 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 532.76 in Q3 2022, with the low at 8954.0 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 2256.56 across 5 years, with a median of 1156.62 in 2024.
- The largest YoY upside for Interest Coverage Ratio was 90.77% in 2022 against a maximum downside of 15568.46% in 2022.
- Sera Prognostics' Interest Coverage Ratio stood at 578.78 in 2022, then tumbled by 38.98% to 804.36 in 2023, then sank by 95.25% to 1570.5 in 2024, then sank by 470.14% to 8954.0 in 2025, then jumped by 47.73% to 4680.0 in 2026.
- The last three Interest Coverage Ratio figures came in at 4680.0 (Q1 2026), 8954.0 (Q4 2025), and 4490.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.98 |
| 10 | Sera Prognostics | 93.48 Mn | 93.48 Mn | -28,000.00 | -4,680.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,680.00 |
| Dec 31, 2025 | -8,954.00 |
| Sep 30, 2025 | -4,490.00 |
| Jun 30, 2025 | -4,660.00 |
| Mar 31, 2025 | -2,312.50 |
| Dec 31, 2024 | -1,570.50 |
| Sep 30, 2024 | -1,772.40 |
| Jun 30, 2024 | -1,156.63 |
| Mar 31, 2024 | -1,010.78 |
| Dec 31, 2023 | -804.36 |
| Sep 30, 2023 | -584.57 |
| Jun 30, 2023 | -818.57 |
| Mar 31, 2023 | -708.06 |
| Dec 31, 2022 | -578.78 |
| Sep 30, 2022 | -532.76 |
| Jun 30, 2022 | -652.56 |
| Mar 31, 2022 | -3,075.00 |
| Dec 31, 2021 | -6,273.50 |
| Sep 30, 2021 | -21.51 |
| Jun 30, 2021 | 3,690.50 |